Real-World, Evidence-Based, Retrospective Study of Patients Infused with Commercially Released Lifileucel for Unresectable or Metastatic Melanoma

Key Points

• Lifileucel infusion demonstrates efficacy in treating unresectable melanoma, showing potential for improved outcomes.
• The study involved a comprehensive retrospective analysis of 75 patients infused with lifileucel over two years.
• Data was collected from multiple clinical centers documenting the treatment response and safety profile.
• These findings support the use of lifileucel as a viable option in advanced melanoma, with a need for larger studies.